Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma
Zhi-Bin Liao1, Xiao-Long Tan1, Ke-Shuai Dong1
1Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Background:
Increasing evidence indicates that aberrant micro (mi)RNA-448 expression plays a critical role in the progression of several human cancers. However, the function of miRNA-448 in hepatocellular carcinoma (HCC) has not been fully investigated.
Methods:
miRNA-448 expression levels in HCC tissues, adjacent non-cancerous tissues (ANTs), and HCC cell lines were examined by quantitative real-time polymerase chain reaction (qRT-PCR). HCC cells were treated with a miRNA-448 mimic or inhibitor, followed by cell viability measurements with the CCK-8 assay. Venn diagram analysis predicted, and dual luciferase reporter assays verified, the target gene of miRNA-448. Expression of the target gene was detected by qRT-PCR and immunohistochemistry. Growth of miRNA-448- or target gene-expressing HCC xenograft tumors in nude mice was measured.
Results:
miRNA-448 was expressed at a lower level in HCC tissues than ANTs, and correlated with a larger tumor size, incomplete tumor encapsulation, and advanced Barcelona Clinic Liver Cancer stage. miRNA-448 inhibited HCC cell growth. The downstream target of miRNA-448 was BCL-2, which was highly expressed in HCC tissues and its mRNA level was negatively correlated with miRNA-448 expression. In vivo, BCL-2 attenuated the tumor inhibiting effect of miRNA-448.
Conclusion:
miRNA-448 functions as a tumor suppressor by targeting BCL-2 in HCC.
Insights
MicroRNA-448 acts as a tumor suppressor in hepatocellular carcinoma (HCC). It inhibits HCC cell growth by targeting BCL-2, suggesting potential therapeutic strategies for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant micro (mi)RNA-448 expression is implicated in human cancer progression.
- The specific role of miRNA-448 in hepatocellular carcinoma (HCC) remains largely unexplored.
Purpose of the Study:
- To investigate the function of miRNA-448 in hepatocellular carcinoma (HCC).
- To identify the downstream target of miRNA-448 and elucidate its mechanism in HCC.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) to assess miRNA-448 expression.
- Cell viability assays (CCK-8) and dual luciferase reporter assays to determine miRNA-448 targets.
- In vivo xenograft tumor models in nude mice to evaluate the therapeutic potential.
Main Results:
- Lower miRNA-448 expression was observed in HCC tissues compared to adjacent non-cancerous tissues (ANTs).
- miRNA-448 significantly inhibited HCC cell growth and proliferation.
- BCL-2 was identified as a direct target of miRNA-448, with its expression negatively correlated with miRNA-448 levels in HCC.
Conclusions:
- miRNA-448 functions as a tumor suppressor in HCC.
- The tumor-suppressive role of miRNA-448 is mediated through the inhibition of BCL-2.
- Targeting the miRNA-448/BCL-2 axis may offer a novel therapeutic strategy for HCC.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Cells Coordinate Growth and Proliferation
Primary and Secondary Growth in Roots and Shoots
Population Growth
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

